These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 19889782)
1. Protective memory responses are modulated by priming events prior to challenge. Rutigliano JA; Morris MY; Yue W; Keating R; Webby RJ; Thomas PG; Doherty PC J Virol; 2010 Jan; 84(2):1047-56. PubMed ID: 19889782 [TBL] [Abstract][Full Text] [Related]
2. Responses of mouse airway epithelial cells and alveolar macrophages to virulent and avirulent strains of influenza A virus. Tate MD; Schilter HC; Brooks AG; Reading PC Viral Immunol; 2011 Apr; 24(2):77-88. PubMed ID: 21449718 [TBL] [Abstract][Full Text] [Related]
3. Suppression of Cytotoxic T Cell Functions and Decreased Levels of Tissue-Resident Memory T Cells during H5N1 Infection. Kandasamy M; Furlong K; Perez JT; Manicassamy S; Manicassamy B J Virol; 2020 Apr; 94(9):. PubMed ID: 32075925 [TBL] [Abstract][Full Text] [Related]
4. Innate immune responses to influenza A H5N1: friend or foe? Peiris JS; Cheung CY; Leung CY; Nicholls JM Trends Immunol; 2009 Dec; 30(12):574-84. PubMed ID: 19864182 [TBL] [Abstract][Full Text] [Related]
5. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza. Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565 [TBL] [Abstract][Full Text] [Related]
6. Passive immunization of mice with IgY anti-H5N1 protects against experimental influenza virus infection and allows development of protective immunity. Eriksson M; Nylén S; Grönvik KO Vaccine; 2024 Nov; 42(25):126133. PubMed ID: 39019655 [TBL] [Abstract][Full Text] [Related]
7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge. Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689 [TBL] [Abstract][Full Text] [Related]
8. Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. Li H; Bradley KC; Long JS; Frise R; Ashcroft JW; Hartgroves LC; Shelton H; Makris S; Johansson C; Cao B; Barclay WS PLoS Pathog; 2018 Jan; 14(1):e1006821. PubMed ID: 29300777 [TBL] [Abstract][Full Text] [Related]
9. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. Bodewes R; Kreijtz JH; Baas C; Geelhoed-Mieras MM; de Mutsert G; van Amerongen G; van den Brand JM; Fouchier RA; Osterhaus AD; Rimmelzwaan GF PLoS One; 2009; 4(5):e5538. PubMed ID: 19440239 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding. Van Hoeven N; Belser JA; Szretter KJ; Zeng H; Staeheli P; Swayne DE; Katz JM; Tumpey TM J Virol; 2009 Apr; 83(7):2851-61. PubMed ID: 19144714 [TBL] [Abstract][Full Text] [Related]
11. Caspase-1 deficient mice are more susceptible to influenza A virus infection with PA variation. Huang CH; Chen CJ; Yen CT; Yu CP; Huang PN; Kuo RL; Lin SJ; Chang CK; Shih SR J Infect Dis; 2013 Dec; 208(11):1898-905. PubMed ID: 23901080 [TBL] [Abstract][Full Text] [Related]
13. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo. Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434 [TBL] [Abstract][Full Text] [Related]
14. Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice. Leung YHC; Nicholls JM; Ho CK; Sia SF; Mok CKP; Valkenburg SA; Cheung P; Hui KPY; Chan RWY; Guan Y; Akira S; Peiris JSM J Gen Virol; 2014 Sep; 95(Pt 9):1870-1879. PubMed ID: 24878639 [TBL] [Abstract][Full Text] [Related]
15. Local innate immune responses and influenza virus transmission and virulence in ferrets. Maines TR; Belser JA; Gustin KM; van Hoeven N; Zeng H; Svitek N; von Messling V; Katz JM; Tumpey TM J Infect Dis; 2012 Feb; 205(3):474-85. PubMed ID: 22158704 [TBL] [Abstract][Full Text] [Related]
16. Differential host determinants contribute to the pathogenesis of 2009 pandemic H1N1 and human H5N1 influenza A viruses in experimental mouse models. Otte A; Sauter M; Alleva L; Baumgarte S; Klingel K; Gabriel G Am J Pathol; 2011 Jul; 179(1):230-9. PubMed ID: 21703405 [TBL] [Abstract][Full Text] [Related]
17. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting. Jenkins MR; Webby R; Doherty PC; Turner SJ J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927 [TBL] [Abstract][Full Text] [Related]
18. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168 [TBL] [Abstract][Full Text] [Related]
19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses. Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745 [TBL] [Abstract][Full Text] [Related]
20. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Reading PC; Whitney PG; Pickett DL; Tate MD; Brooks AG Immunol Cell Biol; 2010 Aug; 88(6):641-50. PubMed ID: 20142836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]